Your browser doesn't support javascript.
loading
Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.
Hayashi, Manabu; Machida, Takeshi; Ishida, Yumi; Ogata, Yusuke; Omori, Tomoko; Takasumi, Mika; Endo, Yuichi; Suzuki, Toshiyuki; Sekimata, Masayuki; Homma, Yoshimi; Ikawa, Masahito; Ohira, Hiromasa; Fujita, Teizo; Sekine, Hideharu.
Afiliação
  • Hayashi M; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Machida T; Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Ishida Y; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan; be204093@fmu.ac.jp.
  • Ogata Y; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Omori T; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Takasumi M; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Endo Y; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Suzuki T; Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Sekimata M; Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Homma Y; Radioisotope Research Center, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Ikawa M; Radioisotope Research Center, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Ohira H; Department of Biomolecular Science, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
  • Fujita T; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan; and.
  • Sekine H; Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
J Immunol ; 203(6): 1411-1416, 2019 09 15.
Article em En | MEDLINE | ID: mdl-31399515
ABSTRACT
The complement system, a part of the innate immune system, can be activated via three different pathways. In the alternative pathway, a factor D (FD) plays essential roles in both the initiation and the amplification loop and circulates as an active form. Mannose-binding lectin-associated serine proteases (MASPs) are key enzymes of the lectin pathway, and MASP-1 and/or MASP-3 are reported to be involved in the activation of FD. In the current study, we generated mice monospecifically deficient for MASP-1 or MASP-3 and found that the sera of the MASP-1-deficient mice lacked lectin pathway activity, but those of the MASP-3-deficient mice lacked alternative pathway activity with a zymogen FD. Furthermore, the results indicate that MASP-3 but not MASP-1 activates the zymogen FD under physiological conditions and MASP-3 circulates predominantly as an active form. Therefore, our study illustrates that, in mice, MASP-3 orchestrates the overall complement reaction through the activation of FD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Fator D do Complemento / Via Alternativa do Complemento / Serina Proteases Associadas a Proteína de Ligação a Manose Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Fator D do Complemento / Via Alternativa do Complemento / Serina Proteases Associadas a Proteína de Ligação a Manose Idioma: En Ano de publicação: 2019 Tipo de documento: Article